Published in:
Open Access
01-11-2013 | Meeting abstract
OR10-005 - Treatment responses in TRAPS: Eurofever/ Eurotraps
Authors:
HJ Lachmann, K Minden, L Obici, A Naselli, A Insalaco, V Hentgen, R Merino, C Modesto, N Toplak, R Berendes, R Cimaz, A Jansson, A Martini, P Woo, I Touitou, M Gattorno
Published in:
Pediatric Rheumatology
|
Special Issue 1/2013
Login to get access
Excerpt
TRAPS is a rare lifelong disease. Optimal treatment is not established but tends to rely either on corticosteroids with risks of known short and long term side effects or anti cytokine agents which are expensive, and both types of agents lead to higher risk of infection. …